Dave Rosa
Chief Executive Officer
Replay available
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2026 earnings conference call, held 2026-02-17. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ron McClurg
Chief Financial Officer
Jeffrey Cohn
Analyst, Ladenburg Thalman
Jeremy Perlman
Analyst, Maxim Group
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neuroone Medical Technologies Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.296 Good day, ladies and gentlemen, and welcome to the first quarter fiscal 2026 financial 00:00:05.296 -- 00:00:10.820 results conference call for NeuroOne Medical Technologies Corporation. 00:00:10.922 -- 00:00:16.007 Today's call will be conducted by the company's chief executive officer, Dave Rosa, 00:00:16.007 -- 00:00:20.412 and Ron McClurg, the company's chief financial officer. 00:00:20.412 -- 00:00:24.556 Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference 00:00:24.556 -- 00:00:26.913 call will include forward-looking statements. 00:00:26.913 -- 00:00:32.100 within the meaning of US federal securities laws with respect to future operations, 00:00:32.100 -- 00:00:37.687 financial results, including our 2026 revenue guidance, events, trends, 00:00:37.687 -- 00:00:42.072 and performance, which are based on management's beliefs and assumptions as of today's 00:00:42.072 -- 00:00:43.894 call. 00:00:43.894 -- 00:00:48.340 Forward-looking statements may involve known and unknown risks, uncertainties, and other 00:00:48.340 -- 00:00:53.066 factors, which may cause actual results to differ materially from those expressed or 00:00:53.066 -- 00:00:55.634 implied by such statements. 00:00:55.634 -- 00:01:00.642 See NeuroOne's financial results press release and SEC filings for information 00:01:00.642 -- 00:01:06.351 regarding specific risks and uncertainties that could cause actual results to differ. 00:01:06.351 -- 00:01:11.659 Except, as required by law, NeuroOne undertakes no obligation to update such forward-looking 00:01:11.659 -- 00:01:13.221 statements. 00:01:13.221 -- 00:01:15.425 With that, I will turn the call over to Mr. 00:01:15.425 -- 00:01:20.092 Dave Rosa, CEO of NeuroOne. Please go ahead, ...